A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
Condition:   Type 2 Diabetes Mellitus Intervention:   Drug: Insulin Glargine Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2019 Category: Research Source Type: clinical trials